Skip to main content

For people 6+ with moderate to severe plaque psoriasis

Purple to pink gradient background

Convenient once-a-month dosing

The recommended dose of COSENTYX® (secukinumab) for moderate-severe plaque psoriasis is 300 mg. To start, your doctor will prescribe 5 weekly loading doses. To continue after that, you only need to take COSENTYX once a month for maintenance, which means fewer interruptions in your daily routine.

Each 300-mg dose is given as 2 injections of 150 mg under the skin.

 COSENTYX Monthly Dosing Chart


For some people, a dose of 150 mg may be acceptable.

COSENTYX is injected with the Sensoready® Pen or a prefilled syringe. Your healthcare provider should show you how to inject COSENTYX before using it for the first time.

Learn more about our devices and watch step-by-step videos on how to take COSENTYX.

COSENTYX comes in the easy-to-use Sensoready Pen, which is designed for comfortable use:

COSENTYX Sensoready Pen self-injection medication

Learn more about how to use the Sensoready Pen and about COSENTYX in the prefilled syringe.

Concealed needle 

You can self-inject safely and confidently
 

Viewing window 

The green indicator assures you that your injection has been completely delivered 
 

Easy, no-button activation 

Automatic 2-click technology allows you to hear when your dose starts and finishes 
 

Ergonomic shape 

Designed to be easy to hold and easy to use 

Results are from clinical trials at week 12.

COSENTYX Sensoready Pen

The Sensoready Pen is easy to get used to:

More than 90% of people reported no pain or reaction during or after the injection§
 

Nearly 9 out of 10 people reported being satisfied or very satisfied with self-injection using the Sensoready Pen§
 

Download this handy brochure with instructions and tips so you have them whenever you need them.

§In a study of patients with active psoriatic arthritis.

Gary Quote Photo

Individual results may vary. Gary was compensated for his time.

“The UPS guy shows up. I put my medicine away. When it’s the day to take it, I put it in. It's practically painless. I'm good to go. I don't think about it for a month, and then I'm excited to call to reorder to have the UPS guy show up again.”

Tap to see IMPORTANT SAFETY INFORMATION AND APPROVED USES

IMPORTANT SAFETY INFORMATION

Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.

COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as…

Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.

COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:

Infections

COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections. Some people have died from these infections.

  • Your doctor should check you for tuberculosis (TB) before starting treatment with COSENTYX.

  • If your doctor feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with COSENTYX and during treatment with COSENTYX.

  • Your doctor should watch you closely watch for signs and symptoms of TB during treatment with COSENTYX. Do not take COSENTYX if you have an active TB infection.

Before starting COSENTYX, tell your doctor if you:

  • are being treated for an infection

  • have an infection that does not go away or that keeps coming back

  • have TB or have been in close contact with someone with TB

  • think you have an infection or have symptoms of an infection such as: fevers, sweats, or chills; muscle aches; cough; shortness of breath; blood in your phlegm; weight loss; warm, red, or painful skin or sores on your body; diarrhea or stomach pain; burning when you urinate or urinate more often than normal

After starting COSENTYX, call your doctor right away if you have any signs of infection listed above. Do not use COSENTYX if you have any signs of infection unless you are instructed to by your doctor.

Inflammatory bowel disease

New cases of inflammatory bowel disease or "flare-ups" can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn's disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.

Serious allergic reactions

Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms; feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; skin rash or hives (red, itchy bumps).

If you have a severe allergic reaction, do not give another injection of COSENTYX.

Severe skin reactions that look like eczema can happen during treatment with COSENTYX from days to months after your first dose and can sometimes lead to hospitalization. Your healthcare provider may temporarily stop treatment with COSENTYX if you develop severe skin reactions. Tell your healthcare provider if you have any of the following signs or symptoms:

  • redness or rash

  • itching

  • small bumps or patches

  • your skin is dry or feels like leather

  • blisters on the hands or feet that ooze or become crusty

  • skin peeling

Before using COSENTYX, tell your doctor if you:

  • have any of the conditions or symptoms listed above for infections.

  • have inflammatory bowel disease (Crohn's disease or ulcerative colitis).

  • are allergic to latex. The needle cap on the COSENTYX Sensoready® pen, and 150 mg/mL and 75 mg/0.5 mL prefilled syringes contains latex.

  • have recently received or are scheduled to receive an immunization (vaccine). People who take COSENTYX should not receive live vaccines. Children should be brought up to date with all vaccines before starting COSENTYX.

  • have any other medical conditions.

  • are pregnant or plan to become pregnant. It is not known if COSENTYX can harm your unborn baby. You and your doctor should decide if you will use COSENTYX.

  • are breastfeeding or plan to breastfeed. It is not known if COSENTYX passes into your breast milk.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of your medicines to show your doctor and pharmacist when you get a new medicine.

How should I use COSENTYX?

Read the detailed Instructions for Use that comes with your COSENTYX for information on how to prepare and inject a dose of COSENTYX, and how to properly throw away (dispose of) used COSENTYX.

  • Use COSENTYX exactly as prescribed by your doctor.

  • If your doctor decides that you or a caregiver may give your injections of COSENTYX at home, you should receive training on the right way to prepare and inject COSENTYX. Do not try to inject COSENTYX yourself, until you or your caregiver has been shown how to inject COSENTYX by your doctor or nurse.

The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory infections. These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or call 1-800-FDA-1088.

Please see full Prescribing Information , including Medication Guide .

7/23 287272

INDICATIONS

COSENTYX® (secukinumab) is a prescription medicine used to treat:

  • people 6 years of age and older with moderate to severe plaque psoriasis (PsO)  that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light alone or with systemic therapy)…

COSENTYX® (secukinumab) is a prescription medicine used to treat:

  • people 6 years of age and older with moderate to severe plaque psoriasis (PsO)  that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light alone or with systemic therapy)

  • people 2 years of age and older with active psoriatic arthritis (PsA)

  • adults with active ankylosing spondylitis (AS)

  • adults with active non-radiographic axial spondyloarthritis (nr-axSpA) and objective signs of inflammation 

  • people 4 years of age and older with active enthesitis-related arthritis (ERA)

*Limitations apply. Up to a $16,000 annual limit. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.